Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 2
2006 1
2007 1
2008 2
2009 3
2010 7
2011 4
2012 3
2014 5
2015 3
2016 6
2017 2
2018 1
2019 7
2020 8
2021 10
2022 6
2023 4
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
Pozzetto B, Legros V, Djebali S, Barateau V, Guibert N, Villard M, Peyrot L, Allatif O, Fassier JB, Massardier-Pilonchéry A, Brengel-Pesce K, Yaugel-Novoa M, Denolly S, Boson B, Bourlet T, Bal A, Valette M, Andrieu T, Lina B; Covid-Ser study group; Cosset FL, Paul S, Defrance T, Marvel J, Walzer T, Trouillet-Assant S. Pozzetto B, et al. Nature. 2021 Dec;600(7890):701-706. doi: 10.1038/s41586-021-04120-y. Epub 2021 Oct 21. Nature. 2021. PMID: 34673755
Type I IFN immunoprofiling in COVID-19 patients.
Trouillet-Assant S, Viel S, Gaymard A, Pons S, Richard JC, Perret M, Villard M, Brengel-Pesce K, Lina B, Mezidi M, Bitker L, Belot A; COVID HCL Study group. Trouillet-Assant S, et al. J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29. J Allergy Clin Immunol. 2020. PMID: 32360285 Free PMC article. No abstract available.
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects.
Saker K, Pozzetto B, Escuret V, Pitiot V, Massardier-Pilonchéry A, Mokdad B, Langlois-Jacques C, Rabilloud M, Alfaiate D, Guibert N, Fassier JB, Bal A, Trouillet-Assant S, Trabaud MA. Saker K, et al. Among authors: escuret v. J Clin Virol. 2022 Jul;152:105169. doi: 10.1016/j.jcv.2022.105169. Epub 2022 Apr 27. J Clin Virol. 2022. PMID: 35568003 Free PMC article.
La balance HA-NA des virus influenza A(H1N1).
Le Briand N, Casalegno JS, Escuret V, Gaymard A, Lina B, Ottmann M, Frobert E. Le Briand N, et al. Among authors: escuret v. Virologie (Montrouge). 2016 Feb 1;20(1):47-60. doi: 10.1684/vir.2016.0628. Virologie (Montrouge). 2016. PMID: 33065852 English.
Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic.
Destras G, Bal A, Escuret V, Morfin F, Lina B, Josset L; COVID-Diagnosis HCL Study Group. Destras G, et al. Among authors: escuret v. Lancet Microbe. 2020 Aug;1(4):e149. doi: 10.1016/S2666-5247(20)30066-5. Epub 2020 Jun 11. Lancet Microbe. 2020. PMID: 32835345 Free PMC article. No abstract available.
Factors Associated with Long COVID-19 in a French Multicentric Prospective Cohort Study.
Khanafer N, Henaff L, Bennia S, Termoz A, Chapurlat R, Escuret V, Proriol M, Duvert F, Mena C, Planckaert C, Trehet-Mandez N, Saadatian-Elahi M, Vanhems P. Khanafer N, et al. Among authors: escuret v. Int J Environ Res Public Health. 2023 Aug 29;20(17):6678. doi: 10.3390/ijerph20176678. Int J Environ Res Public Health. 2023. PMID: 37681818 Free PMC article.
73 results